These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

304 related items for PubMed ID: 26176270

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. PEGylated liposomes with NGR ligand and heat-activable cell-penetrating peptide-doxorubicin conjugate for tumor-specific therapy.
    Yang Y, Yang Y, Xie X, Cai X, Zhang H, Gong W, Wang Z, Mei X.
    Biomaterials; 2014 May; 35(14):4368-81. PubMed ID: 24565519
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. A photo-responsive peptide- and asparagine-glycine-arginine (NGR) peptide-mediated liposomal delivery system.
    Xie X, Yang Y, Yang Y, Zhang H, Li Y, Mei X.
    Drug Deliv; 2016 Sep; 23(7):2445-2456. PubMed ID: 25693640
    [Abstract] [Full Text] [Related]

  • 9. Thermosensitive magnetic liposomes with doxorubicin cell-penetrating peptides conjugate for enhanced and targeted cancer therapy.
    Lin W, Xie X, Yang Y, Fu X, Liu H, Yang Y, Deng J.
    Drug Deliv; 2016 Nov; 23(9):3436-3443. PubMed ID: 27193383
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Novel Class of Ultrasound-Triggerable Drug Delivery Systems for the Improved Treatment of Tumors.
    Zhou C, Xie X, Yang H, Zhang S, Li Y, Kuang C, Fu S, Cui L, Liang M, Gao C, Yang Y, Gao C, Yang C.
    Mol Pharm; 2019 Jul 01; 16(7):2956-2965. PubMed ID: 31084010
    [Abstract] [Full Text] [Related]

  • 12. Inhibition of prostate cancer growth using doxorubicin assisted by ultrasound-targeted nanobubble destruction.
    Fan X, Wang L, Guo Y, Xiong X, Zhu L, Fang K.
    Int J Nanomedicine; 2016 Jul 01; 11():3585-96. PubMed ID: 27536100
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Nanoparticles targeted with NGR motif deliver c-myc siRNA and doxorubicin for anticancer therapy.
    Chen Y, Wu JJ, Huang L.
    Mol Ther; 2010 Apr 01; 18(4):828-34. PubMed ID: 20068551
    [Abstract] [Full Text] [Related]

  • 15. Intelligent "Peptide-Gathering Mechanical Arm" Tames Wild "Trojan-Horse" Peptides for the Controlled Delivery of Cancer Nanotherapeutics.
    Shi NQ, Li Y, Zhang Y, Shen N, Qi L, Wang SR, Qi XR.
    ACS Appl Mater Interfaces; 2017 Dec 06; 9(48):41767-41781. PubMed ID: 29161013
    [Abstract] [Full Text] [Related]

  • 16. Enhanced small interfering RNA delivery into cells by exploiting the additive effect between photo-sensitive peptides and targeting ligands.
    Lin W, Xie X, Yang Y, Liu H, Fu X, Chen Y, Liu H, Yang Y.
    J Pharm Pharmacol; 2015 Sep 06; 67(9):1215-31. PubMed ID: 25880614
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Novel cell-penetrating peptide-loaded nanobubbles synergized with ultrasound irradiation enhance EGFR siRNA delivery for triple negative Breast cancer therapy.
    Jing H, Cheng W, Li S, Wu B, Leng X, Xu S, Tian J.
    Colloids Surf B Biointerfaces; 2016 Oct 01; 146():387-95. PubMed ID: 27388967
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Transferrin and octaarginine modified dual-functional liposomes with improved cancer cell targeting and enhanced intracellular delivery for the treatment of ovarian cancer.
    Deshpande P, Jhaveri A, Pattni B, Biswas S, Torchilin V.
    Drug Deliv; 2018 Nov 01; 25(1):517-532. PubMed ID: 29433357
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.